Skip to main content

Table 2 Characteristics of study participants with and without MetS

From: A cross-sectional assessment of metabolic syndrome in HIV-infected people of low socio-economic status receiving antiretroviral therapy

  MetS (n =  29) No MetS (n =  60) P value
Age (years) 49 ± 4 48 ± 8 0.54
Sex (%)    
Male 12 (41) 29 (48) 0.35
Female 17 (59) 31 (52)  
Duration of HIV (years) 17 ± 7 18 ± 15 0.32
ART (%)    
PI 22 (78) 24 (44) 0.003
Non-PI 6 (21) 30 (55)  
Ethnicity (%)    0.41
Non-Hispanic White 1 (3) 9 (15)  
African-American 22 (76) 36 (60)  
Hispanic 6 (21) 15 (25)  
Employment (%)    0.11
Unemployed 26 (93) 48 (80)  
Employed (part or full time) 2 (7) 12 (20)  
Systolic BP (mmHg) 132 ± 13 122 ± 10 0.000
Diastolic BP (mmHg) 84 ± 9 78 ± 8 0.002
Body mass index (kg/m2) 31.8 ± 7.0 31.0 ± 8.2 0.64
Waist circumference (cm) 108 ± 15.0 105 ± 20 0.46
Waist-hip ratio 0.93 ± 0.07 0.92 ± 0.07 0.38
VO2max (ml/kg/min) 26.5 ± 7.7 27.3 ± 8.4 0.76
1-RM upper body (lbs) 112 ± 49 117 ± 53 0.69
1-RM lower body (lbs) 209 ± 93 232 ± 71 0.24
Current coffee drinker (%) 20 (77) 47 (78) 0.34
Current alcohol drinker (%) 6 (21) 16 (27) 0.54
Current smoker (%) 9 (31) 23 (38) 0.50
Sleep (hours) 6.5 ± 1.7 7 ± 1.8 0.70
  1. Data are means ± SD or n (%).
  2. MetS metabolic syndrome, ART antiretroviral therapy, PI protease inhibitors, BP blood pressure, VO 2max maximal oxygen consumption, 1-RM one repetition maximum.